tiprankstipranks
Trending News
More News >
Whitehawk Therapeutics (WHWK)
NASDAQ:WHWK
US Market

Whitehawk Therapeutics (WHWK) Income Statement

Compare
498 Followers

Whitehawk Therapeutics Income Statement

Last quarter (Q2 2025), Whitehawk Therapeutics's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q2, Whitehawk Therapeutics's net income was $-52.62M. See Whitehawk Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 25.98M$ 24.35M$ 15.22M$ 1.12M$ 14.58M
Gross Profit
$ -28.07M$ -27.38M$ -18.78M$ -18.55M$ -428.00K
Operating Expenses
$ 39.39M$ 44.55M$ 43.90M$ 92.67M$ 2.12M
Depreciation and Amortization
$ 193.00K$ 169.00K$ 159.00K$ 105.00K$ 9.00K
EBITDA
$ -64.63M$ -71.76M$ -58.80M$ -36.96M$ -2.54M
Operating Income
$ -67.46M$ -71.93M$ -62.68M$ -111.22M$ -2.55M
Other Income/Expenses
$ 3.77M$ 6.17M$ 2.17M$ 1.13M$ -927.00K
Pretax Income
$ -63.69M$ -65.77M$ -60.51M$ -110.09M$ -3.48M
Net Income
$ -63.69M$ -65.77M$ -60.51M$ -110.09M$ -3.48M
Per Share Metrics
Basic EPS
$ -2.36$ -2.44$ -2.69$ -12.41$ -0.21
Diluted EPS
$ -2.36$ -2.44$ -2.69$ -12.41$ -0.21
Weighted Average Shares Outstanding
27.03M 26.92M 22.51M 8.87M 20.84M
Weighted Average Shares Outstanding (Diluted)
27.03M 26.92M 22.51M 8.92M 17.63M
Currency in USD

Whitehawk Therapeutics Earnings and Revenue History